IPP Bureau
Mylab receives approval for HPV RT-PCR test for cervical cancers
By IPP Bureau - September 28, 2022
‘PathoDetect HPV Detection Test’ detects and discriminates the presence of high-risk HPV strains including 16 and 18 which cause most of the cervical cancers.
LISSUN raises ~$1 million in pre-Seed round from IvyCap Ventures and others
By IPP Bureau - September 28, 2022
Funds raised will be used to develop technology and foster healthcare partnerships
Carbogen Amcis completes Swissmedic inspection of its facility in Vionnaz, Switzerland
By IPP Bureau - September 28, 2022
This inspection continues a series of successful inspections by Swissmedic in Vionnaz with the first inspection in 2015 followed by 2016, 2017 and 2020.
Hester planning capacity expansion for Goat Pox vaccine
By IPP Bureau - September 27, 2022
Further, ICAR-IVRI have jointly developed a Lumpy Skin Disease vaccine and as soon as the technology is made available, Hester will acquire the same and manufacture and commercialize the Lumpy Skin disease Vaccine
There should be no space for fraud in AB-PMJAY: Dr. Mandaviya
By IPP Bureau - September 27, 2022
The second day of Arogya Manthan 2022 had panel discussions with eminent thought leaders from relevant public and private sector organizations
Pfizer and BioNTech submit application to USFDA for emergency use authorization of Omicron BA.4/BA.5-adapted bivalent vaccine booster for 5-11 year age
By IPP Bureau - September 27, 2022
The companies have also initiated a Phase 1/2/3 study NCT05543616 to evaluate the safety, tolerability, and immunogenicity of different doses
Novartis unveils new focused strategy
By IPP Bureau - September 27, 2022
Transformation to pure-play Innovative Medicines company nears completion
CellOrigin Biotech collaborates with Qilu Pharma to develop CAR-iMAC Cell Therapy
By IPP Bureau - September 27, 2022
NATCO launches Chlorantraniliprole (CTPR) formulated product NATGEN
By IPP Bureau - September 26, 2022
NATCO estimates the current market size of CTPR containing products in India to be over Rs. 2,000 crore.
Alkem to spread awareness through “The Healthy Lungs”
By IPP Bureau - September 26, 2022
Though lungs do not have the celebrity status as the heart, they are one of the most important and delicate organs of the human body
Puneet Sud appointed additional director of Nectar Lifesciences
By IPP Bureau - September 26, 2022
Sud has more than 32 years of work experience with different companies like Clivient, Jubilant Life Sciences, Piramal Enterprises, Parabolic Drugs, Orchid Chemicals and Pharmaceuticals, Ranbaxy Labs, and Lupin
Kiran Mazumdar-Shaw awarded H. K. Firodia Lifetime Achievement Award 2022
By IPP Bureau - September 26, 2022
The committee unanimously decided to confer the Lifetime Achievement Award to Kiran Mazumdar-Shaw for her monumental contributions as a global leader in biotechnology innovation and entrepreneurship
AIIMS New Delhi celebrates 67th Foundation Day
By IPP Bureau - September 26, 2022
India's healthcare system has shown great efficiency not only in providing diagnostic and management facilities but also in minimizing mortality and maximizing recovery
Aptar Pharma collaborates with Fluidda
By IPP Bureau - September 25, 2022
The companies will leverage their respective proprietary technology platforms
Unichem Laboratories sale its stake in Optimus Drugs
By IPP Bureau - September 24, 2022
The company has received payment towards completion of sale of the first tranche from Sekhmet Pharmaventures Private Limited.
